Evidence map›Paper›PMID 39572639›Full record

ArticleScientific reports2024

Stage-based colorectal cancer prediction on uncertain dataset using rough computing and LSTM models.

K Supriya, A Anitha

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

K SupriyaSchool of Computer Science Engineering and Information Systems, Vellore Institute of Technology, Vellore, 632014, India.
A AnithaSchool of Computer Science Engineering and Information Systems, Vellore Institute of Technology, Vellore, 632014, India. aanitha@vit.ac.in.ORCID 0000-0002-6005-8429

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial intelligence (AI) is an attractive field of Computer Science that helps to classify and to predict various real-time applications. Perhaps AI has a major role in predicting diseases at an early stage based on history. As cancer is one of the most harmful diseases where the mortality rate is high, it is now essential to utilize the benefits of AI to have an early diagnosis of cancer. Among various cancers, Colorectal cancer (CRC) is a common form of gastrointestinal cancer, and its treatment is lengthy and costly, with a high recurrence rate and high fatality rate. Initial disease analysis and prognosis are required to improve the patient's treatment with a better survival analysis. However, the disease prediction process depends on the collected data, where the data may contain uncertainty. Uncertain data leads to wrong predictions. Thus, it is essential to utilize rough computing, a mathematical tool to deal with uncertainty. This paper has made an effort, to handle uncertainty using a rough set of fuzzy approximation space as pre-processing and utilized Unidirectional and Bidirectional LSTM for the classification and prediction process. Thus, to demonstrate improved predictive accuracy, the proposed model adapted the optimizers and evaluated using benchmarking techniques in predicting stage-based survival rate. The comparative analysis shows that the proposed model performs well against the state-of-the-art models and can help the medical practitioner to detect CRC at an early stage and reduce the mortality rate among human beings.

Indexed as

Colorectal NeoplasmsArtificial IntelligenceFemaleFuzzy LogicHumansMaleNeoplasm StagingPrognosisUncertaintyColorectal cancer predictionLSTMRough set on fuzzy approximation space (RSFAS)Survival analysisWeibull distribution

Identifiers

PMID39572639
PMCPMC11582363

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.